
11 - 50 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Spyre Therapeutics is a biopharmaceutical company focused on developing therapies for Inflammatory Bowel Disease (IBD). The company is committed to creating best-in-class antibodies, rational therapeutic combinations, and employing precision immunology approaches to enhance treatment efficacy and convenience for IBD patients. With a team experienced in developing and commercializing treatments across various diseases, Spyre Therapeutics is dedicated to improving treatment options and outcomes for patients through advanced research in immunology. The company fosters a collaborative and innovative environment to achieve its mission of providing promising new treatment options for IBD.
🕒 May 27
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Spyre Therapeutics is a biopharmaceutical company focused on developing therapies for Inflammatory Bowel Disease (IBD). The company is committed to creating best-in-class antibodies, rational therapeutic combinations, and employing precision immunology approaches to enhance treatment efficacy and convenience for IBD patients. With a team experienced in developing and commercializing treatments across various diseases, Spyre Therapeutics is dedicated to improving treatment options and outcomes for patients through advanced research in immunology. The company fosters a collaborative and innovative environment to achieve its mission of providing promising new treatment options for IBD.
• Oversee structural and functional characterization and comparability studies across Spyre’s clinical and late-stage mAb and mAb-mAb combination programs. • Provide strategic and technical leadership for multidimensional biologics characterization to support product understanding and comparability in a phase-appropriate manner. • Serve as subject matter expert (SME) in mAb and mAb-mAb combination product molecular characterization and comparability. • Contribute to analytical control strategies and regulatory content development. • Lead comparability and characterization activities at CDMOs. • Ensure analytical activities meet scientific, regulatory and industry standards. • Develop characterization strategies in collaboration with analytical SMEs. • Support ADQC activities, including method development, investigations, and review of QC release and stability data. • Establish best practices and protocols for structure–function relationships and critical quality attribute (CQA) assessment.
• Advanced degree in Mass spectrometry, Biophysical chemistry, Analytical Chemistry, Pharmaceutical Sciences, Biochemistry or a related discipline, with 8+ years of biopharma industry experience in biologics analytical, formulation or process development. • Demonstrated experience and success supporting regulatory submissions (IND, CTA, BLA), with strong expertise in phase-appropriate characterization and comparability studies and associated analytical methods. • Proven leadership and effective communication skills, with the ability to manage biologics program deliverables in a fast-paced environment; experience with mAb combination products is preferred, and device testing is an advantage. • Experience leveraging artificial intelligence (AI) and machine learning (ML) to enhance analytical efficiency, automate attribute trending, and support knowledge generation and decision-making.
• Market competitive compensation and benefits package, including base salary, performance bonus, equity grant opportunities, health, welfare & retirement benefits. • Unlimited PTO • Two, one-week company-wide shutdowns each • Commitment to provide professional development opportunities. • Remote working environment with frequent in-person meetings to address complex problems and build relationships.
Apply Now🕒 May 27
Senior Director of Medical Affairs at ORIC Pharmaceuticals driving medical strategy and execution for oncological therapies. Building key global capabilities and leading scientific engagement activities.
🕒 May 27
Vice President, Senior Director leading Tidal Basin’s Response and Recovery Programs team. Overseeing project portfolio and enhancing growth in disaster recovery services.
🕒 May 26
1001 - 5000
Senior Director of Clinical Programs leading initiatives in rare disease diagnostics and managing a clinical program team at GeneDx.
🕒 May 26
Associate Director leading formulation strategies for bispecific fusion protein development at Dianthus Therapeutics. Focus on protein stability and manufacturability in clinical development.
🕒 May 24
Senior Director of Product Strategy at PowerSchool guiding go-to-market for analytics products. Leading cross-functional teams in delivering educational solutions.